SUHA Pharma Consulting DMPK

Services

Our Services

Independent DMPK & Translational PK Support

SUHA Pharma Consulting supports pharmaceutical, biotechnology and CRO teams with focused PK/TK analysis, translational pharmacokinetics, modeling and scientific reporting—without the overhead of a full-time specialist.

Core capabilities

Five areas where we help turn preclinical data into development-focused insight.

01

Preclinical PK & TK Analysis

Non-compartmental and compartmental analysis of preclinical concentration-time data to characterize exposure, clearance and dose response.

  • NCA and compartmental PK analysis
  • PK parameter estimation and exposure assessment
  • Bioavailability and toxicokinetic interpretation
  • Analysis using Phoenix WinNonlin and R

02

Translational Pharmacokinetics

Bridge preclinical findings to clinical development with scientifically grounded scaling and human exposure prediction.

  • Allometric scaling and human clearance prediction
  • Human exposure and first-in-human dose estimation
  • PK-based clinical translation planning

03

PK Modeling & Simulation

Explore dosing strategies and exposure scenarios before committing to the next study or development milestone.

  • Compartmental modeling and exposure simulation
  • Scenario testing and dose optimization
  • PK profile prediction to support development decisions

04

Tissue Distribution & Excretion

Characterize compound disposition beyond plasma PK—where the drug goes and how it is eliminated.

  • Tissue-to-plasma ratios and organ distribution
  • Urine, fecal and biliary recovery analysis
  • Mass-balance calculations

05

Scientific Reporting & Documentation

Structured, review-ready outputs that communicate findings clearly to scientific and management audiences.

  • PK/TK protocols and study reports
  • Data summaries, tables and publication-quality figures
  • Scientific presentations and management-ready communications

What you receive

Every engagement is designed to move your program toward a clear next decision.

  • Clear PK/TK analysis with scientifically sound interpretation
  • Publication-quality graphs, tables and structured technical reports
  • Translational insights and development-focused recommendations

Tools & methods

Phoenix WinNonlin, R and Excel for PK/TK analysis, modeling, simulation and documentation—selected to match study design and regulatory expectations.

From raw preclinical data to clear, development-focused insight.